MEI Pharma (NASDAQ:MEIP) Downgraded by Zacks Investment Research to Sell

MEI Pharma stock has undergone multiple analysts rating changes in the recent past.  MEI Pharma Downgraded by Zacks Investment Research on 10/14/2021. In a note to investors, the firm issued a new rating of Sell. The analysts previously had rating of Hold.

Shares of MEI Pharma traded down -$0.04 on Wednesday, reaching $3.04. 75 shares of the stock traded hands, compared to its average volume of 507362. Shares of MEI Pharma were trading at $3.04 on Wednesday. The firm’s 50 day moving average is $2.79 and its 200 day moving average is $3.13.MEI Pharma has a 12 month low of $3.00 and a 12 month high of $4.58. While on yearly highs and lows, MEI Pharma’s today has traded high as $3.19 and has touched $3.00 on the downward trend. See More Analyst Rating at: RATING

MEI Pharma Earnings and What to expect: 

MEI Pharma last announced its earnings results on September 7th, 2021. The reported ($0.05) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.17) by $0.12. The firm had revenue of $10.12 million for the quarter, compared to analyst estimates of $5.18 million. MEI Pharma has generated ($0.84) earnings per share over the last year (($0.68) diluted earnings per share). Earnings for MEI Pharma are expected to grow in the coming year, from ($0.59) to ($0.48) per share. MEI Pharma has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Tuesday, November 9th, 2021 based off prior year’s report dates.

Earnings for MEI Pharma are expected to grow in the coming year, from ($0.59) to ($0.48) per share. The P/E ratio of MEI Pharma is -4.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of MEI Pharma is -4.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. MEI Pharma has a P/B Ratio of 8.22. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

MEI Pharma (NASDAQ:MEIP) Moving Average Technical Analysis

5 day Moving Average is $3.06 And 5 day price change is $0.11 (3.75%)  with average volume for 5 day average is 876,760. While technical analysis for average 20 days shows significant difference, 20 day moving average is  $2.85 and 20 day price change is $0.32 (11.76%) and average 20 day moving volume is 570,345. 50 day moving average is $2.79  and 50 day price change is $0.50 ( 19.69%)  and with average volume for 50 days is : 422,174. 200 day moving average is $3.13  and 200 day price change is $0.25 (8.96%)  and with average volume for 200 days is : 690,195.

Other owners latest trading in MEI Pharma :

  • On 9/17/2021 shares held by Virtu Financial LLC were 47,627 which equates to market value of $0.14M and appx 0.00% owners of MEI Pharma
  • On 9/3/2021 shares held by Parametric Portfolio Associates LLC were 34,192 which equates to market value of $97K and appx 0.00% owners of MEI Pharma
  • On 8/23/2021 shares held by Morgan Stanley were 63,616 which equates to market value of $0.18M and appx 0.00% owners of MEI Pharma
  • In total Institutional ownership equates to Institutional Ownership Percentage: 61.19% for MEI Pharma

See More Analyst Rating at: RATING